TawandaGumboMD

Mycobacterial Disease

Director of Research Programs in Global Health & Associate Professor of Medicine

Dr. Gumbo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
UT Southwestern Medical Ctr
5323 Harry Hines BLVD
Dallas, TX 75390
Phone+1 214-648-9914

Fax+1 214-648-2741

Cleveland Clinic FoundationFellowship, Infectious Disease, 1996 - 1999
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1993 - 1996
University of Zimbabwe Huggins SOMClass of 1991

PubMed

1 citations
Ertapenem's therapeutic potential for Mycobacterium avium lung disease in the hollow fibre model.
Devyani Deshpande, Shashikant Srivastava, Tawanda Gumbo
International Journal of Antimicrobial Agents. 2024-09-01
2 citations
Ceftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients.
Devyani Deshpande, Gesham Magombedze, Gunavanthi D Boorgula, Moti Chapagain, Shashikant Srivastava
The Journal of Infectious Diseases. 2024-08-16
Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation.
Gunavanthi D Boorgula, Tawanda Gumbo, Sanjay Singh, Pamela J McShane, Julie V Philley
Tuberculosis. 2024-07-01

Journal Articles

Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, MD, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, Devyani Deshpande, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Devyani Deshpande, Tawanda Gumbo, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Devyani Deshpande, Tawanda Gumbo, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Scott K Heysell, Tawanda Gumbo, Eric R Houpt, Devyani Deshpande, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Devyani Deshpande, Scott K Heysell, Tawanda Gumbo, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Scott K Heysell, Devyani Deshpande, Tawanda Gumbo, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, Devyani Deshpande, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, Devyani Deshpande, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, Devyani Deshpande, Oxford University Press
Join now to see all

Abstracts/Posters

Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, MD, Oxford University Press, Orlando, FL, 12/7/2019

Praedicare Inc. Receives Grant to Evaluate Potential New Drug Regimens for TuberculosisJune 17th, 2021
New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB TreatmentFebruary 24th, 2020
New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB TreatmentFebruary 24th, 2020
Join now to see all

PK-PD Of Combination Antituberculosis Therapy For Suppression Of Drug-ResistanceNational Institute Of Allergy And Infectious Diseases2008–2011
Efflux PUMP Inhibitors To Reduce Duration Of Antituberculosis TherapyOffice Of The Director, National Institutes Of Health2007